Literature DB >> 11834739

Separate functions for the two modules of the membrane-proximal cytokine binding domain of glycoprotein 190, the leukemia inhibitory factor low affinity receptor, in ligand binding and receptor activation.

Mathieu-Benoit Voisin1, Juliette Bitard, Sophie Daburon, Jean-François Moreau, Jean-Luc Taupin.   

Abstract

The receptor for the cytokine leukemia inhibitory factor (LIF) associates the low affinity binding component gp190 and the high affinity converter gp130. Both are members of the hematopoietic receptors family characterized by the cytokine receptor homology (CRH) domain, which consists of two barrel-like modules of around 100 amino acids each. The gp190 is among the very few members of this large family to contain two CRH domains. The membrane-distal one (herein called D1) is followed by an immunoglobulin-like domain, a membrane-proximal CRH domain called D2, and three type III fibronectin-like repeats. A minimal D1IgD2 fragment is required for binding LIF. By using transmembrane forms of deletion mutants in gp190 ectodomain, we demonstrated that removal of D1 led to spontaneous activation of the receptor and that this property was devoted to a peptidic sequence localized within the last 42 amino acids of the carboxyl-terminal module of D2. By using soluble forms of deletion mutants made by progressive truncations from the end of the D1IgD2 fragment, we demonstrated that the carboxyl-terminal module of D2 was dispensable for LIF binding and that the correct conformation of the D1Ig fragment required a full amino-terminal module of D2. Therefore, the two constitutive modules of the membrane-proximal CRH domain D2 of gp190 fulfill two distinct roles in gp190 function, i.e. in stabilizing the conformation of gp190 allowing LIF binding and in activating the receptor.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11834739     DOI: 10.1074/jbc.M111624200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  2 in total

1.  Precise mapping of the CD95 pre-ligand assembly domain.

Authors:  Valérie Edmond; Benoist Ghali; Aubin Penna; Jean-Luc Taupin; Sophie Daburon; Jean-François Moreau; Patrick Legembre
Journal:  PLoS One       Date:  2012-09-25       Impact factor: 3.240

2.  Functional characterization of a chimeric soluble Fas ligand polymer with in vivo anti-tumor activity.

Authors:  Sophie Daburon; Christel Devaud; Pierre Costet; Aurore Morello; Laure Garrigue-Antar; Mike Maillasson; Nathalie Hargous; Delphine Lapaillerie; Marc Bonneu; Julie Dechanet-Merville; Patrick Legembre; Myriam Capone; Jean-François Moreau; Jean-Luc Taupin
Journal:  PLoS One       Date:  2013-01-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.